Selected research
Industry Growth & Trends
Global Metronidazole Injection Industry Growth and Trends Forecast to 2032
Market perspective
The global Metronidazole Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Metronidazole Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Metronidazole Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Metronidazole Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Metronidazole Injection include Pfizer, Baxter, Unique Pharmaceuticals, Sanofi-Aventis Canada Inc, Sagent Pharmaceuticals, Qatar Pharma, JB Chemicals and Pharmaceuticals, B. Braun Medical Inc and AdvaCare Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Metronidazole Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Metronidazole Injection market size, estimates, and forecasts are presented in terms of sales volume (K L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Metronidazole Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Metronidazole Injection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Metronidazole Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Metronidazole Injection Market by Company
Pfizer
Baxter
Unique Pharmaceuticals
Sanofi-Aventis Canada Inc
Sagent Pharmaceuticals
Qatar Pharma
JB Chemicals and Pharmaceuticals
B. Braun Medical Inc
AdvaCare Pharma
Metronidazole Injection Segment by Type
500mg/100mL
50mg/10mL
Metronidazole Injection Segment by Application
Adult Use
Pediatric Use
Geriatric Use
Metronidazole Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metronidazole Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metronidazole Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metronidazole Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metronidazole Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Metronidazole Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 500mg/100mL
- 50mg/10mL
Applications
- Adult Use
- Pediatric Use
- Geriatric Use
Companies covered
- Pfizer
- Baxter
- Unique Pharmaceuticals
- Sanofi-Aventis Canada Inc
- Sagent Pharmaceuticals
- Qatar Pharma
- JB Chemicals and Pharmaceuticals
- B. Braun Medical Inc
- AdvaCare Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Metronidazole Injection Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Metronidazole Injection Sales Estimates and Forecasts (2021-2032)
- 1.3 Metronidazole Injection Market by Type
- 1.3.1 500mg/100mL
- 1.3.2 50mg/10mL
- 1.4 Global Metronidazole Injection Market Size by Type
- 1.4.1 Global Metronidazole Injection Market Size Overview by Type (2021-2032)
- 1.4.2 Global Metronidazole Injection Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Metronidazole Injection Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Metronidazole Injection Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Metronidazole Injection Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Metronidazole Injection Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Metronidazole Injection Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Metronidazole Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Metronidazole Injection Industry Trends
- 2.2 Metronidazole Injection Industry Drivers
- 2.3 Metronidazole Injection Industry Opportunities and Challenges
- 2.4 Metronidazole Injection Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Metronidazole Injection Revenue (2021-2026)
- 3.2 Global Top Players by Metronidazole Injection Sales (2021-2026)
- 3.3 Global Top Players by Metronidazole Injection Price (2021-2026)
- 3.4 Global Metronidazole Injection Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Metronidazole Injection Major Company Production Sites & Headquarters
- 3.6 Global Metronidazole Injection Company, Product Type & Application
- 3.7 Global Metronidazole Injection Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Metronidazole Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Metronidazole Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Metronidazole Injection Tier 1, Tier 2, and Tier 3
4 Metronidazole Injection Regional Status and Outlook
- 4.1 Global Metronidazole Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Metronidazole Injection Historic Market Size by Region
- 4.2.1 Global Metronidazole Injection Sales in Volume by Region (2021-2026)
- 4.2.2 Global Metronidazole Injection Sales in Value by Region (2021-2026)
- 4.2.3 Global Metronidazole Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Metronidazole Injection Forecasted Market Size by Region
- 4.3.1 Global Metronidazole Injection Sales in Volume by Region (2027-2032)
- 4.3.2 Global Metronidazole Injection Sales in Value by Region (2027-2032)
- 4.3.3 Global Metronidazole Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Metronidazole Injection by Application
- 5.1 Metronidazole Injection Market by Application
- 5.1.1 Adult Use
- 5.1.2 Pediatric Use
- 5.1.3 Geriatric Use
- 5.2 Global Metronidazole Injection Market Size by Application
- 5.2.1 Global Metronidazole Injection Market Size Overview by Application (2021-2032)
- 5.2.2 Global Metronidazole Injection Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Metronidazole Injection Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Metronidazole Injection Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Metronidazole Injection Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Metronidazole Injection Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Metronidazole Injection Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Metronidazole Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Pfizer
- 6.1.1 Pfizer Company Information
- 6.1.2 Pfizer Business Overview
- 6.1.3 Pfizer Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Pfizer Metronidazole Injection Product Portfolio
- 6.1.5 Pfizer Recent Developments
- 6.2 Baxter
- 6.2.1 Baxter Company Information
- 6.2.2 Baxter Business Overview
- 6.2.3 Baxter Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Baxter Metronidazole Injection Product Portfolio
- 6.2.5 Baxter Recent Developments
- 6.3 Unique Pharmaceuticals
- 6.3.1 Unique Pharmaceuticals Company Information
- 6.3.2 Unique Pharmaceuticals Business Overview
- 6.3.3 Unique Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Unique Pharmaceuticals Metronidazole Injection Product Portfolio
- 6.3.5 Unique Pharmaceuticals Recent Developments
- 6.4 Sanofi-Aventis Canada Inc
- 6.4.1 Sanofi-Aventis Canada Inc Company Information
- 6.4.2 Sanofi-Aventis Canada Inc Business Overview
- 6.4.3 Sanofi-Aventis Canada Inc Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sanofi-Aventis Canada Inc Metronidazole Injection Product Portfolio
- 6.4.5 Sanofi-Aventis Canada Inc Recent Developments
- 6.5 Sagent Pharmaceuticals
- 6.5.1 Sagent Pharmaceuticals Company Information
- 6.5.2 Sagent Pharmaceuticals Business Overview
- 6.5.3 Sagent Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sagent Pharmaceuticals Metronidazole Injection Product Portfolio
- 6.5.5 Sagent Pharmaceuticals Recent Developments
- 6.6 Qatar Pharma
- 6.6.1 Qatar Pharma Company Information
- 6.6.2 Qatar Pharma Business Overview
- 6.6.3 Qatar Pharma Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Qatar Pharma Metronidazole Injection Product Portfolio
- 6.6.5 Qatar Pharma Recent Developments
- 6.7 JB Chemicals and Pharmaceuticals
- 6.7.1 JB Chemicals and Pharmaceuticals Company Information
- 6.7.2 JB Chemicals and Pharmaceuticals Business Overview
- 6.7.3 JB Chemicals and Pharmaceuticals Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 JB Chemicals and Pharmaceuticals Metronidazole Injection Product Portfolio
- 6.7.5 JB Chemicals and Pharmaceuticals Recent Developments
- 6.8 B. Braun Medical Inc
- 6.8.1 B. Braun Medical Inc Company Information
- 6.8.2 B. Braun Medical Inc Business Overview
- 6.8.3 B. Braun Medical Inc Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 B. Braun Medical Inc Metronidazole Injection Product Portfolio
- 6.8.5 B. Braun Medical Inc Recent Developments
- 6.9 AdvaCare Pharma
- 6.9.1 AdvaCare Pharma Company Information
- 6.9.2 AdvaCare Pharma Business Overview
- 6.9.3 AdvaCare Pharma Metronidazole Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 AdvaCare Pharma Metronidazole Injection Product Portfolio
- 6.9.5 AdvaCare Pharma Recent Developments
7 North America by Country
- 7.1 North America Metronidazole Injection Sales by Country
- 7.1.1 North America Metronidazole Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Metronidazole Injection Sales by Country (2021-2026)
- 7.1.3 North America Metronidazole Injection Sales Forecast by Country (2027-2032)
- 7.2 North America Metronidazole Injection Market Size by Country
- 7.2.1 North America Metronidazole Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Metronidazole Injection Market Size by Country (2021-2026)
- 7.2.3 North America Metronidazole Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Metronidazole Injection Sales by Country
- 8.1.1 Europe Metronidazole Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Metronidazole Injection Sales by Country (2021-2026)
- 8.1.3 Europe Metronidazole Injection Sales Forecast by Country (2027-2032)
- 8.2 Europe Metronidazole Injection Market Size by Country
- 8.2.1 Europe Metronidazole Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Metronidazole Injection Market Size by Country (2021-2026)
- 8.2.3 Europe Metronidazole Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Metronidazole Injection Sales by Country
- 9.1.1 Asia-Pacific Metronidazole Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Metronidazole Injection Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Metronidazole Injection Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Metronidazole Injection Market Size by Country
- 9.2.1 Asia-Pacific Metronidazole Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Metronidazole Injection Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Metronidazole Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Metronidazole Injection Sales by Country
- 10.1.1 South America Metronidazole Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Metronidazole Injection Sales by Country (2021-2026)
- 10.1.3 South America Metronidazole Injection Sales Forecast by Country (2027-2032)
- 10.2 South America Metronidazole Injection Market Size by Country
- 10.2.1 South America Metronidazole Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Metronidazole Injection Market Size by Country (2021-2026)
- 10.2.3 South America Metronidazole Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Metronidazole Injection Sales by Country
- 11.1.1 Middle East and Africa Metronidazole Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Metronidazole Injection Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Metronidazole Injection Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Metronidazole Injection Market Size by Country
- 11.2.1 Middle East and Africa Metronidazole Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Metronidazole Injection Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Metronidazole Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Metronidazole Injection Value Chain Analysis
- 12.1.1 Metronidazole Injection Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Metronidazole Injection Production Mode & Process
- 12.2 Metronidazole Injection Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Metronidazole Injection Distributors
- 12.2.3 Metronidazole Injection Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst